OBJECTIVES: The aim of this study was to determine whether apolipoproteins (apo) B and A-I measured in childhood and adolescence predict atherosclerosis in adulthood. BACKGROUND: Exposure to dyslipidemia in childhood predicts the development of atherosclerosis. Apolipoproteins B and A-I might be good markers of atherogenic dyslipidemia, but there is a paucity of information concerning their importance in childhood. METHODS: Apolipoproteins B and A-I, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, blood pressure, obesity, insulin, C-reactive protein, and smoking were assessed in 1980 and 2001 among 879 subjects in the Cardiovascular Risk in Young Finns Study (ages 3 to 18 years at baseline). Carotid artery intima-media thickness (IMT) and brachial artery flow-mediated dilation (FMD) were measured in 2001 at the age of 24 to 39 years. RESULTS: In subjects ages 12 to 18 years at baseline, apoB and apoB/apoA-I ratio were directly (p < 0.001) related and apoA-I was inversely (p = 0.01) related with adulthood IMT. In subjects ages 3 to 18 years at baseline, apoB (p = 0.02) and the apoB/apoA-I ratio (p < 0.001) were inversely related and apoA-I (p = 0.003) was directly related to adulthood FMD. These relations were not altered when the effects of nonlipid risk factors and adulthood apolipoproteins were taken into account. The apoB/apoA-I ratio measured in adolescence was superior to LDL/HDL ratio (c-values, 0.623 vs. 0.569, p = 0.03) in predicting increased IMT in adulthood (IMT >or=90th percentile and/or carotid plaque). CONCLUSIONS: Apolipoproteins B and A-I measured in children and adolescents reflect a lipoprotein profile predisposing to the development of subclinical atherosclerosis in adulthood. These markers might have value in pediatric lipid risk assessment.
OBJECTIVES: The aim of this study was to determine whether apolipoproteins (apo) B and A-I measured in childhood and adolescence predict atherosclerosis in adulthood. BACKGROUND: Exposure to dyslipidemia in childhood predicts the development of atherosclerosis. Apolipoproteins B and A-I might be good markers of atherogenic dyslipidemia, but there is a paucity of information concerning their importance in childhood. METHODS: Apolipoproteins B and A-I, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, blood pressure, obesity, insulin, C-reactive protein, and smoking were assessed in 1980 and 2001 among 879 subjects in the Cardiovascular Risk in Young Finns Study (ages 3 to 18 years at baseline). Carotid artery intima-media thickness (IMT) and brachial artery flow-mediated dilation (FMD) were measured in 2001 at the age of 24 to 39 years. RESULTS: In subjects ages 12 to 18 years at baseline, apoB and apoB/apoA-I ratio were directly (p < 0.001) related and apoA-I was inversely (p = 0.01) related with adulthood IMT. In subjects ages 3 to 18 years at baseline, apoB (p = 0.02) and the apoB/apoA-I ratio (p < 0.001) were inversely related and apoA-I (p = 0.003) was directly related to adulthood FMD. These relations were not altered when the effects of nonlipid risk factors and adulthood apolipoproteins were taken into account. The apoB/apoA-I ratio measured in adolescence was superior to LDL/HDL ratio (c-values, 0.623 vs. 0.569, p = 0.03) in predicting increased IMT in adulthood (IMT >or=90th percentile and/or carotid plaque). CONCLUSIONS: Apolipoproteins B and A-I measured in children and adolescents reflect a lipoprotein profile predisposing to the development of subclinical atherosclerosis in adulthood. These markers might have value in pediatric lipid risk assessment.
Authors: Brian T Steffen; Weihua Guan; Alan T Remaley; James H Stein; Mathew C Tattersall; Joel Kaufman; Michael Y Tsai Journal: J Clin Lipidol Date: 2017-07-12 Impact factor: 4.766
Authors: Petter Bjornstad; Nhung Nguyen; Christina Reinick; David M Maahs; Franziska K Bishop; Scott A Clements; Janet K Snell-Bergeon; Rachel Lieberman; Laura Pyle; Stephen R Daniels; R Paul Wadwa Journal: Acta Diabetol Date: 2014-12-25 Impact factor: 4.280
Authors: Ana Claudia Gomes Pereira Petisco; Jorge Eduardo Assef; Carlos Alberto de Jesus; Mohamed Hassan Saleh; Jose Eduardo Martins Barbosa; David Costa de Souza Le Bihan; Ibraim Masciarelli França Pinto; Simone Rolim Fernandes Fontes Pedra; Rodrigo Bellio de Mattos Barretto; Amanda Guerra de Moraes Rego Sousa Journal: Int J Cardiovasc Imaging Date: 2016-10-20 Impact factor: 2.357
Authors: Costan G Magnussen; Harri Niinikoski; Markus Juonala; Mika Kivimäki; Tapani Rönnemaa; Jorma S A Viikari; Olli Simell; Olli T Raitakari Journal: Pediatr Nephrol Date: 2011-08-30 Impact factor: 3.714
Authors: David Martinez-Gomez; J Pablo Rey-López; Palma Chillón; Sonia Gómez-Martínez; Germán Vicente-Rodríguez; Miguel Martín-Matillas; Miguel Garcia-Fuentes; Manuel Delgado; Luis A Moreno; Oscar L Veiga; Joey C Eisenmann; Ascension Marcos Journal: BMC Public Health Date: 2010-05-25 Impact factor: 3.295
Authors: Petter Bjornstad; Robert H Eckel; Laura Pyle; Marian Rewers; David M Maahs; Janet K Snell-Bergeon Journal: Am J Cardiol Date: 2015-07-16 Impact factor: 2.778
Authors: Jesús Millán; Xavier Pintó; Anna Muñoz; Manuel Zúñiga; Joan Rubiés-Prat; Luis Felipe Pallardo; Luis Masana; Alipio Mangas; Antonio Hernández-Mijares; Pedro González-Santos; Juan F Ascaso; Juan Pedro-Botet Journal: Vasc Health Risk Manag Date: 2009-09-18